We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Osteopontin Linked to Progressive Lung Scarring in Scleroderma Patients

By LabMedica International staff writers
Posted on 28 Dec 2020
Print article
Image: Schematic diagram of Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis (FVC=forced vital capacity) (Photo courtesy of University of Michigan).
Image: Schematic diagram of Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis (FVC=forced vital capacity) (Photo courtesy of University of Michigan).
Systemic sclerosis (SSc) is an autoimmune disease characterized by a distinct pathogenic triad of microvascular damage, dysregulation of innate and adaptive immunity, and fibrosis involving skin and many internal organs, such as the heart, kidney, and lungs.

Although mortality because of renal involvement has significantly decreased since the adoption of angiotensin pathway blockade, the proportion of deaths because of interstitial lung disease has continued to increase, making it the leading cause of death of SSc patients. Biomarkers that help identify patients at a greater risk of progressive disease are considered vital for successful clinical development of novel treatment modalities.

Scientists from Genentech (South San Francisco, CA, USA) and their colleagues demonstrated that immune complexes (ICs) activate human monocytes to promote lung fibroblast migration partly via osteopontin (OPN) secretion, which is amplified by autocrine monocyte colony stimulating factor (MCSF) and interleukin-6 (IL-6) activity. Osteopontin levels of all the serum samples in patients from different cohorts and in age/sex matched healthy donors were quantified with Human Osteopontin (OPN) Quantikine ELISA Kit (R&D Systems, Inc, Minneapolis, MN, USA). An observational SSc-ILD cohort included 102 SSc patients with high-resolution computed tomography (HRCT).

Bulk and single-cell RNA sequencing demonstrated that elevated OPN expression in SSc lung tissue is enriched in macrophages, partially overlapping with CCL18 expression. Serum OPN is elevated in SSc patients with interstitial lung disease (ILD) and prognosticates future lung function deterioration in SSc cohorts. Serum OPN levels decrease following monoclonal anti-IL-6 receptor treatment, confirming the connection between IL-6 and OPN in SSc patients.

Thiru Ramalingam, MBBS, PhD, a senior author of the study, said, “When the macrophage is activated by immune complexes, we discovered that it secretes an abundance of a protein called osteopontin, previously implicated in fibrosis. High levels of this protein were confirmed by creating an in vitro culture, meaning outside the body, to emulate the immune complex immobilized in a SSc-ILD patient's lung tissue.”

The authors concluded that their data suggest a plausible link between autoantibodies and lung fibrosis progression, where circulating OPN serves as a systemic proxy for immune complexes driven profibrotic macrophage activity, highlighting its potential as a promising biomarker in SSc ILD. The study was published on November 17, 2020 in the journal Cell Reports Medicine.

Related Links:
Genentech
R&D Systems, Inc


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.